Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Simulation-Based Training in Cardiac Surgery.

Feins RH, Burkhart HM, Conte JV, Coore DN, Fann JI, Hicks GL Jr, Nesbitt JC, Ramphal PS, Schiro SE, Shen KR, Sridhar A, Stewart PW, Walker JD, Mokadam NA.

Ann Thorac Surg. 2017 Jan;103(1):312-321. doi: 10.1016/j.athoracsur.2016.06.062. Epub 2016 Aug 25.

PMID:
27570162
2.

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis.

Ferslew BC, Xie G, Johnston CK, Su M, Stewart PW, Jia W, Brouwer KL, Barritt AS 4th.

Dig Dis Sci. 2015 Nov;60(11):3318-28. doi: 10.1007/s10620-015-3776-8. Epub 2015 Jul 3.

3.

Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis.

Ferslew BC, Johnston CK, Tsakalozou E, Bridges AS, Paine MF, Jia W, Stewart PW, Barritt AS 4th, Brouwer KL.

Clin Pharmacol Ther. 2015 Apr;97(4):419-27. doi: 10.1002/cpt.66. Epub 2015 Mar 15.

4.

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.

Sterling RK, Kuo A, Rustgi VK, Sulkowski MS, Stewart TG, Fenkel JM, El-Genaidi H, Mah'moud MA, Abraham GM, Stewart PW, Akushevich L, Nelson DR, Fried MW, Di Bisceglie AM.

Aliment Pharmacol Ther. 2015 Apr;41(7):671-85. doi: 10.1111/apt.13095. Epub 2015 Jan 28.

5.
6.

Monthly haemostatic factor variability in women and men.

Hill AM, Stewart PW, Fung MK, Kris-Etherton PM, Ginsberg HN, Tracy RP, Pearson TA, Lefevre M, Reed RG, Elmer PJ, Holleran S, Ershow AG; Dietary Effects on Lipoproteins and Thrombogenic Activity Investigators.

Eur J Clin Invest. 2014;44(3):309-18. doi: 10.1111/eci.12235.

7.

Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.

Köck K, Ferslew BC, Netterberg I, Yang K, Urban TJ, Swaan PW, Stewart PW, Brouwer KL.

Drug Metab Dispos. 2014 Apr;42(4):665-74. doi: 10.1124/dmd.113.054304. Epub 2013 Oct 23.

8.

Predictive value of initial triage vital signs for critically ill older adults.

Lamantia MA, Stewart PW, Platts-Mills TF, Biese KJ, Forbach C, Zamora E, McCall BK, Shofer FS, Cairns CB, Busby-Whitehead J, Kizer JS.

West J Emerg Med. 2013 Sep;14(5):453-60. doi: 10.5811/westjem.2013.5.13411.

9.

Ozone exposure-response model for lung function changes: an alternate variability structure.

McDonnell WF, Stewart PW, Smith MV.

Inhal Toxicol. 2013 May;25(6):348-53. doi: 10.3109/08958378.2013.790523.

PMID:
23742111
10.

Confidence regions for repeated measures ANOVA power curves based on estimated covariance.

Gribbin MJ, Chi YY, Stewart PW, Muller KE.

BMC Med Res Methodol. 2013 Apr 15;13:57. doi: 10.1186/1471-2288-13-57.

11.

Effect of a vascular endothelial cadherin antagonist in a rat lung transplant model.

Tian Z, Dong B, Blackwell JW, Stewart PW, Egan TM.

Ann Thorac Surg. 2013 Mar;95(3):1028-33. doi: 10.1016/j.athoracsur.2012.11.023. Epub 2013 Jan 17.

PMID:
23333062
12.

Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors.

Dong B, Stewart PW, Egan TM.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):429-36.e1. doi: 10.1016/j.jtcvs.2012.11.005. Epub 2012 Dec 20.

13.

The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans.

Ilic K, Hawke RL, Thirumaran RK, Schuetz EG, Hull JH, Kashuba AD, Stewart PW, Lindley CM, Chen ML.

Drug Metab Dispos. 2013 Mar;41(3):575-81. doi: 10.1124/dmd.112.048108. Epub 2012 Dec 13.

14.

Prediction of lung function response for populations exposed to a wide range of ozone conditions.

McDonnell WF, Stewart PW, Smith MV, Kim CS, Schelegle ES.

Inhal Toxicol. 2012 Aug;24(10):619-33. doi: 10.3109/08958378.2012.705919.

PMID:
22906168
15.

Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.

Coloe Dosal J, Stewart PW, Lin JA, Williams CS, Morrell DS.

Pediatr Dermatol. 2014 Jul-Aug;31(4):440-9. doi: 10.1111/j.1525-1470.2012.01810.x. Epub 2012 Aug 16.

16.

Issues in the interpretation of associations of PCBs and IQ.

Stewart PW, Reihman J, Lonky E, Pagano J.

Neurotoxicol Teratol. 2012 Jan-Feb;34(1):96-107. doi: 10.1016/j.ntt.2011.11.003. Epub 2011 Nov 30.

PMID:
22146557
17.

Recommendations for planning pilot studies in clinical and translational research.

Moore CG, Carter RE, Nietert PJ, Stewart PW.

Clin Transl Sci. 2011 Oct;4(5):332-7. doi: 10.1111/j.1752-8062.2011.00347.x. Review.

18.

Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales.

Kipp AM, Pungrassami P, Stewart PW, Chongsuvivatwong V, Strauss RP, Van Rie A.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1540-5, i. doi: 10.5588/ijtld.10.0273.

19.

Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis.

Joy MS, Boyette T, Hu Y, Wang J, La M, Hogan SL, Stewart PW, Falk RJ, Dooley MA, Smith PC.

Eur J Clin Pharmacol. 2010 Nov;66(11):1119-30. doi: 10.1007/s00228-010-0846-x. Epub 2010 Jun 22.

20.

Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas.

Noah TL, Ivins SS, Abode KA, Stewart PW, Michelson PH, Harris WT, Henry MM, Leigh MW.

Pediatr Pulmonol. 2010 Mar;45(3):281-90. doi: 10.1002/ppul.21176.

PMID:
20146365

Supplemental Content

Loading ...
Support Center